Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

June 30, 2006

Study Completion Date

November 30, 2006

Conditions
Hepatitis B
Interventions
BIOLOGICAL

hepatitis B vaccine

Trial Locations (38)

10315

GSK Investigational Site, Berlin

12627

GSK Investigational Site, Berlin

13355

GSK Investigational Site, Berlin

17192

GSK Investigational Site, Waren

24161

GSK Investigational Site, Altenholz

24937

GSK Investigational Site, Flensburg

24943

GSK Investigational Site, Flensburg

24944

GSK Investigational Site, Flensburg

25813

GSK Investigational Site, Husum

25821

GSK Investigational Site, Bredstedt

38226

GSK Investigational Site, Salzgitter

40699

GSK Investigational Site, Erkrath

42579

GSK Investigational Site, Heiligenhaus

47533

GSK Investigational Site, Kleve-Materborn

47798

GSK Investigational Site, Krefeld

47877

GSK Investigational Site, Willich

54290

GSK Investigational Site, Trier

54294

GSK Investigational Site, Trier

66901

GSK Investigational Site, Schoeneberg - Kuebelberg

70469

GSK Investigational Site, Stuttgart

74357

GSK Investigational Site, Bönnigheim

74523

GSK Investigational Site, Schwäbisch Hall

77654

GSK Investigational Site, Offenburg

77694

GSK Investigational Site, Kehl

77704

GSK Investigational Site, Oberkirch

77955

GSK Investigational Site, Ettenheim

78532

GSK Investigational Site, Tuttlingen

80939

GSK Investigational Site, Munich

81241

GSK Investigational Site, Munich

81735

GSK Investigational Site, Munich

82327

GSK Investigational Site, Tutzing

82362

GSK Investigational Site, Weilheim

85354

GSK Investigational Site, Freising

86720

GSK Investigational Site, Nördlingen

86899

GSK Investigational Site, Landsberg am Lech

86916

GSK Investigational Site, Kaufering

88348

GSK Investigational Site, Bad Saulgau

93413

GSK Investigational Site, Cham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY